Biogen and Eisai revive plans for Alzheimer’s drug, surprising market
The field of experimental Alzheimer’s treatments is littered with high-profile failures, with many major drugmakers abandoning the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Biogen
Biogen scraps two late-stage trials for Alzheimer’s treatment
The decision was based on the results of a review conducted by a data safety monitoring board, which recommended discontinuing the…